Clinical Trials Logo

Clinical Trial Summary

Phase IIb, randomized, double-blind, placebo-controlled study in parallel groups assessing the efficacy and safety of two doses of SOM3355 in patients suffering from Huntington's Disease with choreic movements.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05475483
Study type Interventional
Source SOM Innovation Biotech SA
Contact
Status Active, not recruiting
Phase Phase 2
Start date August 2, 2022
Completion date June 2024